CPET | GKT | ||||||
---|---|---|---|---|---|---|---|

VER | Δ% | VER | Δ% | Test p | Phase p | T*P p | |

Maximal Oxygen Uptake(mL·kg^{-1}·min^{-1}) |
58.1 (4.2) | -0.2 (7.1) | 55.6 (6.1) | -0.1 (10.1) | 0.13 (0.56) | 0.22 (0.44) | 0.36 (0.32) |

Maximal Heart Rate (beats·min^{-1}) |
188(9) | -2.1 (2.2) | 190(6) | -1.2 (1.1) | 1.00 (0.00) | 0.002* (1.41) | 0.18 (0.48) |

Maximal RespiratoryExchange Ratio (V̇CO_{2}/V̇O_{2}) |
1.02 (0.07) | -12.9 (9.3) | 0.97 (0.06) | -20.5 (9.2) | 0.64 (0.16) | <0.001* (2.21) | 0.03* (0.83) |

Maximal Expired Minute Ventilation (L·min^{-1}) |
124.1 (15.2) | -2.6 (11.0) | 127.5 (17.1) | -3.0 (7.3) | 0.35 (0.33) | 0.17 (0.50) | 0.93 (0.03) |

Verification PhaseDuration (s) ^{NP} |
96(38) | - | 94(45) | - | 0.06 (0.60) | - | - |

Parametric data presented as mean (standard deviation) and non-parametric (^{NP}) data presented as median (interquartile range). Physiological outcomes compared with Two-way repeated measures ANOVA. Verification Phase Duration was compared with Wilcoxon Test. CPET - Running Cardiopulmonary Exercise Test. GKT – Graded Karate Test. VER – Verification Phase. Δ% - Percentage difference of Verification phase and Incremental maximal outcomes [(Incremental-Verification)/Incremental]. ES – Effect size (Cohen’s f for physiological outcomes and r (Z√n) for verification phase duration). * denotes significant difference (p ≤ 0.05). T*P – Test and phase interaction.